Prevention

Monthly Subcutaneous Galcanezumab Effective for Migraine Prevention

Monthly Subcutaneous Galcanezumab Effective for Migraine Prevention

By

Monthly subcutaneous injections of galcanezumab at either 120 mg or 300 mg were effective for preventing migraines.

Migraines Possibly Prevented With Prophylactic Magnesium

Migraines Possibly Prevented With Prophylactic Magnesium

By

The included trials looked at magnesium administration among those with menstrual migraine, migraine with and without aura, and standard migraine symptoms.

Episodic Migraines Possibly Prevented With Subcutaneous Galcanezumab

Episodic Migraines Possibly Prevented With Subcutaneous Galcanezumab

Researchers have found that monthly subcutaneous injection of galcanezumab significantly reduce migraine headache days.

New Migraine Treatment Devices Available to Stop and Prevent Attacks

New Migraine Treatment Devices Available to Stop and Prevent Attacks

By

The FDA has approved 2 new migraine treatment devices to stop and prevent migraine attacks in adults.

Current and Emerging Behavioral Treatments for Migraine: Expert Q&A

Current and Emerging Behavioral Treatments for Migraine: Expert Q&A

By

Some patients with migraines prefer nonpharmacological approaches to treatment and for these patients, evidence-based behavioral treatments may be at least as effective for migraine prophylaxis as medication.

Diabetic Neuropathy: Updated Position Statement by the American Diabetes Association

Diabetic Neuropathy: Updated Position Statement by the American Diabetes Association

By

The American Diabetes Association released an updated position statement on the prevention, detection, and management of diabetic neuropathies.

Sign Up for Free e-Newsletters